Published in Addiction on October 01, 2008
Relationship of life-course drinking patterns to diabetes, heart problems, and hypertension among those 40 and older in the 2005 U.S. National Alcohol Survey. J Stud Alcohol Drugs (2010) 1.01
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology (2011) 0.96
Update in addiction medicine for the generalist. J Gen Intern Med (2010) 0.83
COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study. Am J Hypertens (2008) 0.79
Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcohol Clin Exp Res (2009) 0.79
High Blood Pressure and Related Factors Among Individuals at High Risk for HIV/Sexually Transmitted Infections. J Clin Hypertens (Greenwich) (2015) 0.75
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. Drug Alcohol Depend (2017) 0.75
Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict (1989) 6.58
Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens (2006) 3.29
Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension (2005) 2.43
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
Dose-dependent biphasic effect of ethanol on 24-h blood pressure in normotensive subjects. Am J Hypertens (1999) 1.69
Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension (2001) 1.68
Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension (1996) 1.45
Prospective study of moderate alcohol consumption and risk of hypertension in young women. Arch Intern Med (2002) 1.23
Alcohol and hypertension: an update. Hypertension (2006) 1.02
Higher prevalence of systemic hypertension among moderate alcohol drinkers: an exploration of the role of underreporting. J Stud Alcohol (2006) 1.01
Alcohol intake and future incidence of hypertension in a general Japanese population: the Hisayama study. Alcohol Clin Exp Res (2002) 0.95
Alcohol consumption predicts hypertension but not diabetes. J Stud Alcohol (2004) 0.94
Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension: does it matter? Yes. J Cardiovasc Risk (2003) 0.92
Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich) (2005) 0.91
One-year hypertension incidence and its predictors in a working population: the IHPAF study. J Hum Hypertens (2004) 0.89
Influence of pattern of alcohol intake on blood pressure in regular drinkers: a controlled trial. J Hypertens (1998) 0.89
High blood pressure, alcohol and cardiovascular risk. J Hypertens (2005) 0.87
Effects of alcohol restriction on ambulatory blood pressure, heart rate, and heart rate variability in Japanese men. Am J Hypertens (2002) 0.83
Effect of alcohol abstinence on blood pressure: assessment by 24-hour ambulatory blood pressure monitoring. Hypertension (1999) 0.82
Mortality studies in the long-term evaluation of treatment of alcoholics. Alcohol Alcohol Suppl (1993) 0.80
Effects of alcohol withdrawal on 24 hour ambulatory blood pressure among alcohol-dependent patients. Alcohol Clin Exp Res (2003) 0.78
Serum gamma-glutamyl transferase levels and blood pressure falls after alcohol moderation. Clin Exp Hypertens (1997) 0.78
Alcohol consumption and changes in blood pressure among African Americans. The Pitt County Study. Am J Epidemiol (1997) 0.78
Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA (2007) 6.81
Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology (2004) 2.69
Prospective relations between social support and depression: differential direction of effects for parent and peer support? J Abnorm Psychol (2004) 2.41
Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology (2010) 2.16
Alcohol screening and brief counseling in a primary care hypertensive population: a quality improvement intervention. Addiction (2008) 2.02
Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry (2009) 1.97
Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry (2008) 1.80
Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry (2011) 1.76
Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol (2012) 1.63
Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med (2007) 1.63
Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry (2011) 1.63
Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology (2010) 1.58
Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res (2005) 1.35
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med (2008) 1.34
Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav (2009) 1.27
What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res (2007) 1.26
Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol (2012) 1.24
Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol Clin Exp Res (2006) 1.22
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res (2011) 1.18
A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene. Neuropsychopharmacology (2002) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol (2009) 1.13
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res (2008) 1.12
Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcohol Clin Exp Res (2004) 1.12
Knowledge and attitudes about pharmacotherapy for alcoholism: a survey of counselors and administrators in community-based addiction treatment centres. Alcohol Alcohol (2006) 1.12
Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. J Stud Alcohol Drugs (2008) 1.12
Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res (2012) 1.09
A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res (2004) 1.07
Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence. Alcohol Clin Exp Res (2009) 1.07
Improving acceptance of naltrexone in community addiction treatment centers: a pilot study. J Subst Abuse Treat (2008) 1.07
5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder. Psychiatr Genet (2011) 1.05
Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology (2012) 1.03
Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol (2003) 1.01
Depression and coronary artery atherosclerosis and reactivity in female cynomolgus monkeys. Psychosom Med (2002) 1.01
The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J Stud Alcohol (2006) 1.01
Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry (2009) 1.00
Following alcohol consumption, nontreatment-seeking alcoholics report greater stimulation but similar sedation compared with social drinkers. J Stud Alcohol (2004) 0.99
Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol Clin Exp Res (2014) 0.98
Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials. Alcohol Clin Exp Res (2014) 0.98
Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. Alcohol Clin Exp Res (2008) 0.98
Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res (2004) 0.97
Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage (2011) 0.97
Childhood adversity increases risk for nicotine dependence and interacts with α5 nicotinic acetylcholine receptor genotype specifically in males. Neuropsychopharmacology (2011) 0.95
Biochemical alcohol screening in primary health care. Addict Behav (2004) 0.95
Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics. Alcohol Clin Exp Res (2003) 0.95
Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study. J Stud Alcohol Drugs (2009) 0.95
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res (2009) 0.94
Editorial commentary: alcohol biomarker papers. Alcohol Clin Exp Res (2010) 0.94
Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry (2006) 0.93
Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol (2009) 0.93
The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol (2010) 0.93
Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients. Alcohol Clin Exp Res (2012) 0.93
A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women. Am J Med Genet B Neuropsychiatr Genet (2011) 0.91
Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich) (2005) 0.91
Do negative emotions predict alcohol consumption, saturated fat intake, and physical activity in older adults? Behav Modif (2005) 0.91
Design and analysis of trials of combination therapies. J Stud Alcohol Suppl (2005) 0.90
Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets (2010) 0.90
Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women. Alcohol Alcohol (2012) 0.89
GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcohol Clin Exp Res (2011) 0.88
Confirmatory analysis of the adolescent obsessive compulsive drinking scale (A-OCDS): a measure of 'craving' and problem drinking in adolescents/young adults. J Natl Med Assoc (2002) 0.87
Behavioral medicine in the prevention and treatment of cardiovascular disease. Behav Modif (2003) 0.87
Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material. Clin Chem Lab Med (2010) 0.87
Prevalence of problem drinking and characteristics of a single-question screen. J Emerg Med (2008) 0.87
Subtypes of major depression in substance dependence. Addiction (2009) 0.87
Methamphetamine abuse and oral health: a pilot study of "meth mouth". Quintessence Int (2012) 0.86
Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. J Hum Genet (2012) 0.86
Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics. Addict Biol (2011) 0.85
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. Psychopharmacology (Berl) (2014) 0.85
Association of COL25A1 with comorbid antisocial personality disorder and substance dependence. Biol Psychiatry (2012) 0.84
Integration and sustainability of alcohol screening, brief intervention, and pharmacotherapy in primary care settings. J Stud Alcohol Drugs (2013) 0.83
Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series. Alcohol Clin Exp Res (2010) 0.83
The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict (2002) 0.83
Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study. Drug Alcohol Depend (2013) 0.82
Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. Behav Brain Funct (2012) 0.82
Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence. Pharmacogenomics (2008) 0.82
Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol (2010) 0.81
The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence. Psychiatry (Edgmont) (2006) 0.81
Recessive genetic mode of an ADH4 variant in substance dependence in African-Americans: A model of utility of the HWD test. Behav Brain Funct (2008) 0.81
Alcohol biomarker screening in medical and surgical settings. Alcohol Clin Exp Res (2006) 0.81
Coordinating and monitoring multisite clinical trials that combine pharmacological and behavioral treatments. J Stud Alcohol Suppl (2005) 0.80
Agitated depression in substance dependence. Drug Alcohol Depend (2011) 0.80
Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders? Compr Psychiatry (2004) 0.80
COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study. Am J Hypertens (2008) 0.79
Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol (2014) 0.79
Self-report and biomarker alcohol screening by primary care physicians: the need to translate research into guidelines and practice. Alcohol Alcohol (2004) 0.79
Variation in NGFB is associated with primary affective disorders in women. Am J Med Genet B Neuropsychiatr Genet (2011) 0.78
Population admixture modulates risk for alcohol dependence. Hum Genet (2009) 0.78
Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl) (2013) 0.78
Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res (2011) 0.78
Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification. J Addict Med (2007) 0.76
Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible. Clin Chem Lab Med (2013) 0.76
Organizational attributes and screening and brief intervention in primary care. Addict Behav (2013) 0.76
Detecting alcohol use disorders in recently hospitalized persons: results from the national epidemiologic survey on alcohol and related conditions. J Addict Med (2007) 0.75
Health-related quality of life in urban surgical emergency department patients: comparison with a representative German population sample. Health Qual Life Outcomes (2005) 0.75
Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbid. Addict Behav (2012) 0.75
Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine. J Anxiety Disord (2013) 0.75
A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence. Alcohol Clin Exp Res (2013) 0.75